Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT)
What is the purpose of this trial?
The primary objective of this study is to evaluate the impact of N-acetylcysteine (NAC) 1200 mg versus matched placebo (PBO) twice daily, added to contingency management (CM), on cannabis use among treatment-seeking cannabis-dependent adults (ages 18-50).
- 18 Years - 50 Years
- National Institute on Drug Abuse
- Last Updated:
- Study HIC#: